Developing Growth Fund
Daily price w/o sales charge as of 01/23/2020
$19.56
$0.03
YTD Returns w/o sales charge as of 01/23/2020
4.99%
Please click here for performance current to the most recent quarter-end and month-end.
Closed to new investors, with the exception of certain retirement and benefit plans and existing mutual funds advisory programs.
Summary
Summary
The Fund seeks to deliver long-term growth of capital by investing primarily in stocks of small U.S. companies.
Fund Basicsas of 12/31/2019
- Total Net Assets
- $1.84 B
- Inception Date
- 09/28/2007
- Dividend Frequency
- Annually
- Fund Expense Ratio
- 1.19%
- Number of Holdings
- 98
Fund Expense Ratio :
1.19%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 09/28/2007 |
|---|
| w/o sales charge | 31.63% | 31.63% | 21.38% | 9.54% | 14.17% | 9.41% |
| Lipper Category Avg. Small-Cap Growth Funds | 29.08% | 29.08% | 14.48% | 10.07% | 12.85% | - |
| Russell 2000® Growth Index | 28.48% | 28.48% | 12.49% | 9.34% | 13.01% | 8.60% |
Fund Expense Ratio :
1.19%
Fund Expense Ratio :
1.19%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 09/28/2007 |
|---|
| w/o sales charge | 31.63% | 31.63% | 21.38% | 9.54% | 14.17% | 9.41% |
| Lipper Category Avg. Small-Cap Growth Funds | 29.08% | 29.08% | 14.48% | 10.07% | 12.85% | - |
| Russell 2000® Growth Index | 28.48% | 28.48% | 12.49% | 9.34% | 13.01% | 8.60% |
Fund Expense Ratio :
1.19%
Returns with sales charges reflect a maximum sales charge of 5.75%.
TEN LARGEST HOLDINGS as of 12/31/2019View Portfolio
| Holding | Assets |
|---|---|
| Generac Holdings, Inc. | 2.9% |
| Repligen Corp. | 2.3% |
| YETI Holdings Inc | 2.1% |
| Nevro Corp. | 2.1% |
| Inspire Medical Systems Inc | 2.0% |
| Inphi Corp. | 2.0% |
| Mirati Therapeutics, Inc. | 1.7% |
| Coherus Biosciences, Inc. | 1.7% |
| Planet Fitness, Inc. | 1.7% |
| Five9, Inc. | 1.6% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 12/31/2019View Portfolio
| Sector | Weighting |
|---|
| Sector | Weighting |
|---|---|
| Communication Services | |
| Real Estate | |
| Utilities | |
| Not Classified | |
| Consumer Discretionary | |
| Consumer Staples | |
| Energy | |
| Financials | |
| Health Care | |
| Industrials | |
| Information Technology | |
| Materials |
Investment Team
Your Representative
To contact your representative, enter your zip code and select your channel below.
Performance
Performance
Fund Expense Ratio :
1.19%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 09/28/2007 |
|---|
| w/o sales charge | 31.63% | 31.63% | 21.38% | 9.54% | 14.17% | 9.41% |
| Lipper Category Avg. Small-Cap Growth Funds | 29.08% | 29.08% | 14.48% | 10.07% | 12.85% | - |
| Russell 2000® Growth Index | 28.48% | 28.48% | 12.49% | 9.34% | 13.01% | 8.60% |
Fund Expense Ratio :
1.19%
Fund Expense Ratio :
1.19%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 09/28/2007 |
|---|
| w/o sales charge | 31.63% | 31.63% | 21.38% | 9.54% | 14.17% | 9.41% |
| Lipper Category Avg. Small-Cap Growth Funds | 29.08% | 29.08% | 14.48% | 10.07% | 12.85% | - |
| Russell 2000® Growth Index | 28.48% | 28.48% | 12.49% | 9.34% | 13.01% | 8.60% |
Fund Expense Ratio :
1.19%
Returns with sales charges reflect a maximum sales charge of 5.75%.
| Year | Fund Returns | Russell 2000® Growth Index |
|---|
| 2019 | 31.63% | 28.48% |
| 2018 | 4.79% | -9.31% |
| 2017 | 29.64% | 22.17% |
| 2016 | -2.99% | 11.32% |
| 2015 | -9.10% | -1.38% |
| 2014 | 3.09% | 5.60% |
| 2013 | 56.97% | 43.30% |
| 2012 | 10.20% | 14.59% |
| 2011 | -1.81% | -2.91% |
| 2010 | 36.27% | 29.09% |
| 2009 | 46.84% | - |
| 2008 | -47.57% | - |
| 2007 | 35.63% | - |
| Year | Q1 | Q2 | Q3 | Q4 | Yearly Returns |
|---|
| 2020 | - | - | - | - | 4.99% |
| 2019 | 26.92% | 9.07% | -11.41% | 7.34% | 31.63% |
| 2018 | 7.05% | 14.94% | 12.10% | -24.03% | 4.79% |
| 2017 | 8.28% | 4.01% | 7.00% | 7.58% | 29.64% |
| 2016 | -10.36% | 2.16% | 10.77% | -4.37% | -2.99% |
| 2015 | 7.06% | 2.57% | -15.74% | -1.76% | -9.10% |
| 2014 | 1.65% | 0.12% | -5.80% | 7.53% | 3.09% |
| 2013 | 13.48% | 10.00% | 18.72% | 5.92% | 56.97% |
| 2012 | 12.15% | -2.74% | 5.55% | -4.27% | 10.20% |
| 2011 | 10.19% | 1.46% | -20.89% | 11.03% | -1.81% |
| 2010 | 8.10% | -7.97% | 16.48% | 17.59% | 36.27% |
| 2009 | -2.17% | 24.23% | 14.22% | 5.78% | 46.84% |
| 2008 | -21.83% | 6.59% | -11.82% | -28.64% | -47.57% |
| 2007 | 4.60% | 13.56% | 9.80% | 3.99% | 35.63% |
NAV Historical Prices
| Date | Net Asset Value |
|---|
Portfolio
Portfolio
| Holding | Sector | Assets |
|---|
| Generac Holdings, Inc. | Industrials | 2.9% |
| Repligen Corp. | Health Care | 2.3% |
| YETI Holdings Inc | Consumer Discretionary | 2.1% |
| Nevro Corp. | Health Care | 2.1% |
| Inspire Medical Systems Inc | Health Care | 2.0% |
| Inphi Corp. | Information Technology | 2.0% |
| Mirati Therapeutics, Inc. | Health Care | 1.7% |
| Coherus Biosciences, Inc. | Health Care | 1.7% |
| Planet Fitness, Inc. | Consumer Discretionary | 1.7% |
| Five9, Inc. | Information Technology | 1.6% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
| Holding | Sector | Assets |
|---|
| Generac Holdings, Inc. | Industrials | 2.9% |
| Repligen Corp. | Health Care | 2.4% |
| Inspire Medical Systems Inc | Health Care | 2.2% |
| YETI Holdings Inc | Consumer Discretionary | 2.0% |
| Nevro Corp. | Health Care | 2.0% |
| Inphi Corp. | Information Technology | 2.0% |
| Five9, Inc. | Information Technology | 1.7% |
| Coherus Biosciences, Inc. | Health Care | 1.7% |
| Paylocity Holding Corp. | Information Technology | 1.7% |
| Planet Fitness, Inc. | Consumer Discretionary | 1.7% |
| Blueprint Medicines Corp. | Health Care | 1.6% |
| Penumbra, Inc. | Health Care | 1.5% |
| Chegg, Inc. | Consumer Discretionary | 1.5% |
| Verra Mobility Corp | Information Technology | 1.5% |
| Bright Horizons Family Solutions, Inc. | Consumer Discretionary | 1.5% |
| Avalara Inc | Information Technology | 1.5% |
| Monolithic Power Systems, Inc. | Information Technology | 1.4% |
| ACADIA Pharmaceuticals, Inc. | Health Care | 1.4% |
| Tandem Diabetes Care, Inc. | Health Care | 1.4% |
| Mirati Therapeutics, Inc. | Health Care | 1.4% |
| MKS Instruments, Inc. | Information Technology | 1.4% |
| Insulet Corp. | Health Care | 1.4% |
| LGI Homes, Inc. | Consumer Discretionary | 1.4% |
| Silicon Laboratories, Inc. | Information Technology | 1.3% |
| Coupa Software Inc | Information Technology | 1.3% |
| Federal Signal Corp. | Industrials | 1.3% |
| Teladoc Health | Health Care | 1.3% |
| Anaplan Inc | Information Technology | 1.2% |
| Herman Miller, Inc. | Industrials | 1.2% |
| Lithia Motors, Inc. | Consumer Discretionary | 1.2% |
| Alteryx Inc | Information Technology | 1.2% |
| Western Alliance Bancorp | Financials | 1.2% |
| 10X Genomics Inc | Health Care | 1.2% |
| Calavo Growers, Inc. | Consumer Staples | 1.1% |
| CRISPR Therapeutics AG | Health Care | 1.1% |
| Trex Co., Inc. | Industrials | 1.1% |
| SVMK Inc | Information Technology | 1.1% |
| Globant SA | Information Technology | 1.1% |
| Bridgebio Pharma Inc | Health Care | 1.1% |
| Cubic Corp | Industrials | 1.1% |
| Malibu Boats, Inc. | Consumer Discretionary | 1.1% |
| Axon Enterprise, Inc. | Industrials | 1.1% |
| Masimo Corp. | Health Care | 1.1% |
| Freshpet, Inc. | Consumer Staples | 1.1% |
| Tetra Tech, Inc. | Industrials | 1.0% |
| MasTec, Inc. | Industrials | 1.0% |
| Cirrus Logic, Inc. | Information Technology | 1.0% |
| Roku Inc | Communication Services | 1.0% |
| Assetmark Financial Holdings Inc | Financials | 1.0% |
| Appian Corp | Information Technology | 0.9% |
| Argenx SE | Health Care | 0.9% |
| CenterState Banks, Inc. | Financials | 0.9% |
| RBC Bearings, Inc. | Industrials | 0.9% |
| Guardant Health Inc | Health Care | 0.9% |
| Semtech Corp. | Information Technology | 0.9% |
| Sarepta Therapeutics, Inc. | Health Care | 0.9% |
| Comtech Telecommunications Corp. | Information Technology | 0.9% |
| Goosehead Insurance Inc | Financials | 0.8% |
| Q2 Holdings, Inc. | Information Technology | 0.8% |
| Wix.com Ltd. | Information Technology | 0.8% |
| Strategic Education, Inc. | Consumer Discretionary | 0.8% |
| Asbury Automotive Group, Inc. | Consumer Discretionary | 0.8% |
| Boston Beer Co., Inc. | Consumer Staples | 0.8% |
| SolarEdge Technologies, Inc. | Information Technology | 0.8% |
| Glaukos Corp. | Health Care | 0.8% |
| OSI Systems, Inc. | Information Technology | 0.8% |
| BJ's Wholesale Club Holdings Inc | Consumer Staples | 0.7% |
| Medallia Inc | Information Technology | 0.7% |
| Redfin Corp | Real Estate | 0.7% |
| Wingstop, Inc. | Consumer Discretionary | 0.7% |
| eHealth, Inc. | Financials | 0.7% |
| LivePerson, Inc. | Information Technology | 0.7% |
| Amarin Corp. plc | Health Care | 0.7% |
| Grand Canyon Education, Inc. | Consumer Discretionary | 0.7% |
| Fox Factory Holding Corp. | Consumer Discretionary | 0.7% |
| uniQure NV | Health Care | 0.7% |
| Novanta Inc | Information Technology | 0.6% |
| HUYA Inc | Communication Services | 0.6% |
| Turning Point Therapeutics Inc | Health Care | 0.6% |
| Sage Therapeutics, Inc. | Health Care | 0.6% |
| Everbridge, Inc. | Information Technology | 0.5% |
| iRhythm Technologies, Inc. | Health Care | 0.5% |
| Grocery Outlet Holding Corp | Consumer Staples | 0.5% |
| HubSpot, Inc. | Information Technology | 0.5% |
| RealReal Inc/The | Consumer Discretionary | 0.5% |
| Helen of Troy Ltd. | Consumer Discretionary | 0.5% |
| CareDx Inc | Health Care | 0.5% |
| GW Pharmaceuticals plc | Health Care | 0.5% |
| Lumentum Holdings, Inc. | Information Technology | 0.4% |
| ChemoCentryx Inc | Health Care | 0.4% |
| NextCure Inc | Health Care | 0.4% |
| Karuna Therapeutics Inc | Health Care | 0.3% |
| Lovesac Co/The | Consumer Discretionary | 0.3% |
| Audentes Therapeutics Inc | Health Care | 0.3% |
| National Vision Holdings Inc | Consumer Discretionary | 0.1% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 12/31/2019
| Sector | Weighting | Fund Change from Previous Quarter |
|---|
| Sector | Weighting | Fund Change from Previous Quarter |
|---|---|---|
| Communication Services |
 0.1%
|
|
| Real Estate |
0.8%
|
|
| Utilities | 0.0% | |
| Not Classified | 0.0% | |
| Consumer Discretionary |
1.7%
|
|
| Consumer Staples |
0.7%
|
|
| Energy |
0.6%
|
|
| Financials |
1.3%
|
|
| Health Care |
1.1%
|
|
| Industrials | 0.0% | |
| Information Technology |
0.3%
|
|
| Materials | 0.0% |
Portfolio Details as of 12/31/2019
- Total Net Assets
- $1.84 B
- Number of Holdings
- 98
- Weighted Average Market Cap.
- 4.2 B
- P/B Ratio
- 6.1x
- Portfolio Turnover Ratio as of 07/31/2019
- 88.2%
- P/E Ratio
- 30.8x
To view definitions for the above Portfolio Details, Click here.
Market Capitalization Breakdown - Morningstar separates stock portfolio holdings into five market-capitalization groups: Giant, Large, Mid, Small, and Micro. Of the 5000 largest domestic stocks in their equities database, the top 1% are categorized as Giant, the next 4% are Large, the next 15% are Mid, the next 30% are Small, and the remaining 50% are Micro. Stocks outside of the largest 5000 are also classified as Micro.
Weighted Average Market Cap - The average market capitalization of all companies held in the portfolio with each company weighted according to its percent held in the portfolio. The result is based upon a weighted average of the securities held in the fund.
P/B Ratio - A ratio that helps determine whether a stock is undervalued or overvalued. It is calculated by dividing a stock's price per share by its book value per share. The result is based upon a weighted average of the securities held in the fund.
P/E Ratio - Is the weighted average of each holding's P/E ratio (price of a stock divided by its earnings per share). The result is based upon a weighted average of the securities held in the fund.
Portfolio Turnover - This is a measure of the Fund’s trading activity which is computed by taking the lesser of purchases or sales divided by average monthly market value, excluding short-term investments. The resulting percentage represents the percentage of the portfolio’s holdings that have changed over the past year.
Contributors & Detractors as of 12/31/2019
Contributors
| Holding | Contribution |
|---|---|
| Generac Holdings, Inc. | 0.7% |
| Mirati Therapeutics, Inc. | 0.7% |
| Nevro Corp. | 0.6% |
| Bridgebio Pharma Inc | 0.5% |
| Yeti Hldgs Inc | 0.4% |
Detractors
| Holding | Contribution |
|---|---|
| The Realreal Inc | -0.4% |
| Sage Therapeutics, Inc. | -0.3% |
| LGI Homes, Inc. | -0.2% |
| Appian Corp | -0.2% |
| Huya Inc | -0.2% |
% Contribution reflects the effect of the individual stock's performance on the Fund's overall performance for the period. Individual holdings and their effect on Fund performance may change significantly over time. Investors should consider the overall performance of the Fund before making a decision on whether or not to invest in the Fund.
Attribution Analysis
| Developing Growth Fund | Benchmark | Variance | |||||
|---|---|---|---|---|---|---|---|
| Sector | Avg. Weight | Base Return | Avg. Weight | Base Return | Stock Selection | Group Weight | Total |
The total base return displayed for the Fund does not capture daily cash flow and trading activity and therefore is subject to reasonable variance from the Fund's actual return. Please refer to the Fund's performance results for longer-term returns. The Fund is actively managed and portfolio characteristics, such as individual holdings and sector weightings, may change significantly over time.
Source: Wilshire Attribution Software. GICS sector classification; non-GICS securities classified by Lord Abbett. Sectors may include many industries.
Dividends & Cap Gains
Dividends & Cap Gains
Upcoming Dividend Payment Dates
This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date | Reinvest & Payable Date |
|---|---|---|
| 11/23/2020 | 11/24/2020 | 11/24/2020 |
Capital Gains Distributions
| Record Date | Reinvest & Payable Date | Long-term | Short-term * | Total | Reinvest Price |
|---|---|---|---|---|---|
| 11/20/2019 | 11/21/2019 | $4.4885 | - | $4.4885 | $17.81 |
Taxed as ordinary income
Lord Abbett does not provide tax advice. It is strongly recommended that you discuss the impact of dividends and distributions with your tax advisor.
Upcoming Capital Gain Distribution
This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date |
|---|---|
| 11/23/2020 | 11/24/2020 |
Fees & Expenses
Fees & Expenses
Expense Ratioas of 12/31/2019
| 1.19% |
Fund Documents
Fund Documents
Download fund documents & literature, create email subscriptions, and place direct mail order
|
0Documents selected
|
Order | ||||
|---|---|---|---|---|---|
|
Summary Prospectus
Publish Date:11/03/2015
|
|||||
| n/a |
Statutory Prospectus
Publish Date:11/03/2015
|
||||
| n/a |
Prospectus (XBRL)
Publish Date:11/03/2015
|
||||
|
SAI
Publish Date:11/03/2015
|
|||||
|
Annual Report
Publish Date:11/03/2015
|
|||||
|
Semi-Annual Report
Publish Date:11/03/2015
|
|||||
|
Fact Sheet
Publish Date:11/03/2015
|
|||||
|
Commentary
Publish Date:11/03/2015
|
|||||